Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 58

1.

Perioperative Use of Vedolizumab is not Associated with Postoperative Infectious Complications in Patients with Ulcerative Colitis Undergoing Colectomy.

Ferrante M, de Buck van Overstraeten A, Schils N, Moens A, Van Assche G, Wolthuis A, Vermeire S, D'Hoore A.

J Crohns Colitis. 2017 Jul 12. doi: 10.1093/ecco-jcc/jjx095. [Epub ahead of print]

PMID:
28981886
2.

Folic acid reduces doxorubicin-induced cardiomyopathy by modulating endothelial nitric oxide synthase.

Octavia Y, Kararigas G, de Boer M, Chrifi I, Kietadisorn R, Swinnen M, Duimel H, Verheyen FK, Brandt MM, Fliegner D, Cheng C, Janssens S, Duncker DJ, Moens AL.

J Cell Mol Med. 2017 Jun 13. doi: 10.1111/jcmm.13231. [Epub ahead of print]

3.

Normal and high eNOS levels are detrimental in both mild and severe cardiac pressure-overload.

van Deel ED, Octavia Y, de Boer M, Juni RP, Tempel D, van Haperen R, de Crom R, Moens AL, Merkus D, Duncker DJ.

J Mol Cell Cardiol. 2015 Nov;88:145-54. doi: 10.1016/j.yjmcc.2015.10.001. Epub 2015 Oct 3.

PMID:
26436984
4.

Interaction between digoxin and dronedarone in the PALLAS trial.

Hohnloser SH, Halperin JL, Camm AJ, Gao P, Radzik D, Connolly SJ; PALLAS investigators.

Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1019-25. doi: 10.1161/CIRCEP.114.002046. Epub 2014 Nov 6.

5.

Geranylgeranylacetone blocks doxorubicin-induced cardiac toxicity and reduces cancer cell growth and invasion through RHO pathway inhibition.

Sysa-Shah P, Xu Y, Guo X, Pin S, Bedja D, Bartock R, Tsao A, Hsieh A, Wolin MS, Moens A, Raman V, Orita H, Gabrielson KL.

Mol Cancer Ther. 2014 Jul;13(7):1717-28. doi: 10.1158/1535-7163.MCT-13-0965. Epub 2014 Apr 15.

6.

Preparation of thick uranium layers on aluminium and stainless steel backings.

Benedik L, Sibbens G, Moens A, Eykens R, Nečemer M, Skapin SD, Kump P.

Appl Radiat Isot. 2014 May;87:238-41. doi: 10.1016/j.apradiso.2013.11.052. Epub 2013 Dec 14.

PMID:
24373873
7.

Multi-layer ²³⁵UF₄-⁶LiF-Au targets for high-resolution fission fragment measurements.

Sibbens G, Moens A, Vanleeuw D, Eykens R, Oberstedt S.

Appl Radiat Isot. 2014 May;87:229-32. doi: 10.1016/j.apradiso.2013.11.061. Epub 2013 Dec 4.

PMID:
24355303
8.

Oxidative stress and pathological changes after coronary artery interventions.

Juni RP, Duckers HJ, Vanhoutte PM, Virmani R, Moens AL.

J Am Coll Cardiol. 2013 Apr 9;61(14):1471-81. doi: 10.1016/j.jacc.2012.11.068. Review.

9.

Oxidative and nitrosative stress in the maintenance of myocardial function.

Zhang Y, Tocchetti CG, Krieg T, Moens AL.

Free Radic Biol Med. 2012 Oct 15;53(8):1531-40. doi: 10.1016/j.freeradbiomed.2012.07.010. Epub 2012 Jul 20. Review.

PMID:
22819981
10.

Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies.

Octavia Y, Tocchetti CG, Gabrielson KL, Janssens S, Crijns HJ, Moens AL.

J Mol Cell Cardiol. 2012 Jun;52(6):1213-25. doi: 10.1016/j.yjmcc.2012.03.006. Epub 2012 Mar 21. Review.

11.

Nitroso-redox balance in control of coronary vasomotor tone.

Taverne YJ, de Beer VJ, Hoogteijling BA, Juni RP, Moens AL, Duncker DJ, Merkus D.

J Appl Physiol (1985). 2012 May;112(10):1644-52. doi: 10.1152/japplphysiol.00479.2011. Epub 2012 Feb 23.

12.

Tackling endothelial dysfunction by modulating NOS uncoupling: new insights into its pathogenesis and therapeutic possibilities.

Kietadisorn R, Juni RP, Moens AL.

Am J Physiol Endocrinol Metab. 2012 Mar 1;302(5):E481-95. doi: 10.1152/ajpendo.00540.2011. Epub 2011 Dec 13. Review. Erratum in: Am J Physiol Endocrinol Metab. 2012 Dec 15;303(12):E1505.

13.

Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.

Kowey PR, Crijns HJ, Aliot EM, Capucci A, Kulakowski P, Radzik D, Roy D, Connolly SJ, Hohnloser SH; ALPHEE Study Investigators.

Circulation. 2011 Dec 13;124(24):2649-60. doi: 10.1161/CIRCULATIONAHA.111.072561. Epub 2011 Nov 14.

14.

Dronedarone in high-risk permanent atrial fibrillation.

Connolly SJ, Camm AJ, Halperin JL, Joyner C, Alings M, Amerena J, Atar D, Avezum Á, Blomström P, Borggrefe M, Budaj A, Chen SA, Ching CK, Commerford P, Dans A, Davy JM, Delacrétaz E, Di Pasquale G, Diaz R, Dorian P, Flaker G, Golitsyn S, Gonzalez-Hermosillo A, Granger CB, Heidbüchel H, Kautzner J, Kim JS, Lanas F, Lewis BS, Merino JL, Morillo C, Murin J, Narasimhan C, Paolasso E, Parkhomenko A, Peters NS, Sim KH, Stiles MK, Tanomsup S, Toivonen L, Tomcsányi J, Torp-Pedersen C, Tse HF, Vardas P, Vinereanu D, Xavier D, Zhu J, Zhu JR, Baret-Cormel L, Weinling E, Staiger C, Yusuf S, Chrolavicius S, Afzal R, Hohnloser SH; PALLAS Investigators.

N Engl J Med. 2011 Dec 15;365(24):2268-76. doi: 10.1056/NEJMoa1109867. Epub 2011 Nov 14. Erratum in: N Engl J Med. 2012 Feb 16;366(7):672.

15.

NADPH oxidase-dependent oxidative stress in the failing heart: From pathogenic roles to therapeutic approach.

Octavia Y, Brunner-La Rocca HP, Moens AL.

Free Radic Biol Med. 2012 Jan 15;52(2):291-7. doi: 10.1016/j.freeradbiomed.2011.10.482. Epub 2011 Nov 3. Review.

PMID:
22080085
16.

Thrombospondin-4 is required for stretch-mediated contractility augmentation in cardiac muscle.

Cingolani OH, Kirk JA, Seo K, Koitabashi N, Lee DI, Ramirez-Correa G, Bedja D, Barth AS, Moens AL, Kass DA.

Circ Res. 2011 Dec 9;109(12):1410-4. doi: 10.1161/CIRCRESAHA.111.256743. Epub 2011 Oct 27.

17.

Tackling reperfusion injury after cardiopulmonary bypass with tetrahydrobiopterin: new therapeutic potentials for this phenylketonuria drug?

Octavia Y, Assman NL, Moens AL.

Eur J Cardiothorac Surg. 2012 Jan;41(1):233-4. doi: 10.1016/j.ejcts.2011.04.040. No abstract available.

18.

Role of sepiapterin on endothelial nitric oxide synthase in acute kidney injury: an enigmatic story.

Juni RP, Moens AL.

J Cardiovasc Pharmacol. 2011 Sep;58(3):335; author reply 335-336. doi: 10.1097/FJC.0b013e31822ba174. No abstract available.

PMID:
21897153
19.

Apixaban with antiplatelet therapy after acute coronary syndrome.

Alexander JH, Lopes RD, James S, Kilaru R, He Y, Mohan P, Bhatt DL, Goodman S, Verheugt FW, Flather M, Huber K, Liaw D, Husted SE, Lopez-Sendon J, De Caterina R, Jansky P, Darius H, Vinereanu D, Cornel JH, Cools F, Atar D, Leiva-Pons JL, Keltai M, Ogawa H, Pais P, Parkhomenko A, Ruzyllo W, Diaz R, White H, Ruda M, Geraldes M, Lawrence J, Harrington RA, Wallentin L; APPRAISE-2 Investigators.

N Engl J Med. 2011 Aug 25;365(8):699-708. doi: 10.1056/NEJMoa1105819. Epub 2011 Jul 24.

20.

Endothelial dysfunction after right coronary artery remodeling: a new pathogenetic role of eNOS uncoupling?

Octavia Y, Wingler K, Schmidt HH, Moens AL.

J Appl Physiol (1985). 2011 Jul;111(1):329; author reply 330. doi: 10.1152/japplphysiol.00376.2011. No abstract available.

Supplemental Content

Loading ...
Support Center